Affiliation:
1. University Institute of Pharma Sciences (UIPS), Chandigarh University, Mohali, Punjab, India
Abstract
Abstract:
A number of journal articles written by researchers claiming Tinospora cordifolia
(Giloy) is to blame for liver damage have sparked a wide range of debates between Ayush and the
allopathic medical community, particularly in India. Some even argue that promoting Giloy-based
formulations to the general public is a bad idea. In this backdrop, the purpose of this essay is to
provide a counter-narrative based on some of the major gaps in the research that implicated Giloy
in Drug-induced Liver Injury (DILI). Time-tested herb, Giloy, which has been used for pharmacological
benefits since antiquity, as well as clinical and toxicological evidence suggest that Giloy is
safe, and the observed negative effects can be attributed to Tinospora crispa, a herb that resembles
Tinospora cordifolia in appearance. Holding Giloy species to be detrimental is unjustifiable unless
other variables such as authentication, standardization, Good Agricultural and Collection Practices
(GACP), Good Manufacturing Practices (GMP), regularization of the market are considered. This
article emphasizes the importance of strategic collaboration between plants and contemporary
medicine in order to eliminate concerns about the use of Giloy by the general public.
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献